西藏药业 - Financials

西藏药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
+Revenue	3.0B	2.8B	3.1B	2.6B	2.1B
Revenue Growth %	6.2%	-10.4%	22.7%	19.4%	--
Total Revenue	3.0B	2.8B	3.1B	2.6B	2.1B
Cost Of Revenue	172.0M	162.0M	155.0M	147.0M	223.0M
+Gross Profit	2.8B	2.6B	3.0B	2.4B	1.9B
Gross Margin %	94.2%	94.2%	95.1%	94.2%	89.6%
Total Operating Cost	2.0B	1.9B	2.3B	2.1B	2.0B
Selling Expenses	1.6B	1.6B	1.8B	1.4B	1.2B
Admin Expenses	129.0M	122.0M	124.0M	132.0M	99.5M
Rd Expenses	74.1M	28.9M	17.4M	88.1M	60.9M
Finance Expenses	-69.1M	-47.2M	-33.7M	4.3M	6.7M
+Operating Income	1.0B	1.2B	899.0M	465.0M	257.0M
Operating Margin %	35.0%	41.3%	28.7%	18.2%	12.0%
Non Operating Income	329,800	361,200	2.6M	332,400	4.1M
Non Operating Expenses	3.5M	8.7M	3.5M	1.6M	6.1M
Investment Income	7.5M	15.1M	40.4M	7.0M	-6.8M
Fair Value Change Income	1.7M	-19.0M	-211.0M	-14.2M	153.0M
Asset Disposal Income	108,700	2.0M	533,900	7,700	-35,800
Asset Impairment Loss	4.8M	-197,600	194.0M	277.0M	461.0M
Other Income	46.2M	222.0M	187.0M	6.4M	2.5M
Income Before Tax	1.0B	1.2B	898.0M	463.0M	255.0M
Income Tax	124.0M	95.0M	88.0M	88.1M	41.8M
+Net Income	917.0M	1.1B	810.0M	375.0M	213.0M
Net Margin %	30.8%	37.7%	25.8%	14.7%	10.0%
Net Income Attributable	938.0M	1.1B	801.0M	370.0M	209.0M
Minority Interest	-21.0M	5.8M	9.3M	5.5M	4.1M
Eps Basic	2.91	3.26	2.48	1.49	0.84
Eps Diluted	2.91	3.26	2.48	1.49	0.84

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
Cash And Equivalents	2.3B	1.6B	1.9B	1.1B	764.0M
Trading Financial Assets	1.1B	977.0M	515.0M	792.0M	538.0M
Accounts Receivable	694.0M	527.0M	651.0M	447.0M	471.0M
Notes Receivable	83.3M	33.4M	15.6M	1.2M	65.4M
Notes And Accounts Receivable	778.0M	560.0M	667.0M	448.0M	537.0M
Prepayments	16.2M	11.4M	13.5M	9.6M	12.9M
Inventory	181.0M	134.0M	111.0M	99.9M	137.0M
Total Current Assets	4.6B	3.6B	3.4B	2.7B	2.2B
Long Term Equity Investment	372.0M	86.6M	92.8M	110.0M	110.0M
Fixed Assets	615.0M	604.0M	538.0M	396.0M	488.0M
Fixed Assets Total	615.0M	604.0M	538.0M	396.0M	488.0M
Construction In Progress	39.5M	65.1M	60.7M	154.0M	272.0M
Construction In Progress Total	39.5M	65.1M	60.7M	154.0M	272.0M
Intangible Assets	301.0M	184.0M	202.0M	416.0M	412.0M
Long Term Deferred Expenses	4.3M	1.3M	625,100	1.5M	2.9M
Total Non Current Assets	1.6B	1.2B	1.2B	1.4B	1.6B
Total Assets	6.3B	4.7B	4.6B	4.1B	3.8B
Short Term Borrowings	800.0M	272.0M	500.0M	486.0M	535.0M
Accounts Payable	39.2M	25.4M	38.9M	42.2M	101.0M
Advance Receipts	122,200	172,800	193,700	37,700	513,100
Contract Liabilities	3.0M	4.9M	9.8M	5.3M	3.3M
Total Current Liabilities	1.6B	767.0M	1.2B	1.0B	1.1B
Long Term Borrowings	--	--	--	--	--
Total Non Current Liabilities	490.0M	28.7M	29.3M	42.7M	48.0M
Total Liabilities	2.1B	795.0M	1.2B	1.1B	1.2B
Paid In Capital	322.0M	322.0M	248.0M	248.0M	248.0M
Capital Reserve	752.0M	1.2B	1.3B	1.3B	1.3B
Surplus Reserve	163.0M	163.0M	126.0M	126.0M	126.0M
Retained Earnings	2.5B	2.2B	1.6B	1.3B	1.0B
Minority Equity	339.0M	34.3M	29.0M	19.0M	14.7M
Equity Attributable	3.8B	3.9B	3.3B	3.0B	2.6B
Total Equity	4.1B	4.0B	3.4B	3.0B	2.6B

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
Cash From Sales	3.1B	3.3B	3.3B	2.8B	2.1B
Tax Refunds Received	1.6M	--	11.6M	85.6M	--
Total Operating Cash Inflow	3.3B	3.5B	3.5B	3.0B	2.1B
Cash Paid For Goods	219.0M	197.0M	199.0M	186.0M	239.0M
Cash Paid To Employees	108.0M	104.0M	102.0M	106.0M	81.5M
Taxes Paid	380.0M	501.0M	455.0M	358.0M	275.0M
Total Operating Cash Outflow	2.3B	2.5B	2.5B	2.1B	1.8B
Operating Cash Flow	1.0B	995.0M	1.1B	837.0M	367.0M
Total Investing Cash Inflow	4.6B	4.9B	3.0B	1.6B	370.0M
Total Investing Cash Outflow	5.1B	4.6B	3.8B	2.1B	1.1B
Investing Cash Flow	-589.0M	354.0M	-832.0M	-561.0M	-741.0M
Cash From Borrowings	960.0M	533.0M	700.0M	486.0M	577.0M
Dividends And Interest Paid	615.0M	506.0M	496.0M	99.3M	136.0M
Debt Repayments	482.0M	761.0M	686.0M	534.0M	52.7M
Total Financing Cash Inflow	1.0B	535.0M	702.0M	492.0M	577.0M
Total Financing Cash Outflow	1.1B	1.3B	1.2B	637.0M	200.0M
Financing Cash Flow	-123.0M	-733.0M	-484.0M	-145.0M	377.0M
Net Change In Cash	271.0M	624.0M	-245.0M	171.0M	-12.0M
Ending Cash Balance	1.6B	1.3B	682.0M	927.0M	756.0M
Capex	16.0M	37.6M	21.7M	102.0M	426.0M